Jane Street Group, LLC Regenxbio Inc. Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

A detailed history of Jane Street Group, LLC transactions in Regenxbio Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 38,776 shares of RGNX stock, worth $293,534. This represents 0.0% of its overall portfolio holdings.

Number of Shares

38,776

Previous 94,970 59.17%

Holding current value

$293,534

Previous $1.11 Million 63.46%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$10.49 - $14.39 $589,475 - $808,631	-56,194 Reduced 59.17%	38,776 $406,000
Q2 2024 Aug 14, 2024	BUY	$11.51 - $21.53 $1.09 Million - $2.04 Million	94,970 New	94,970 $1.11 Million
Q4 2023 Feb 14, 2024	BUY	$12.89 - $20.82 $185,719 - $299,974	14,408 Added 48.16%	44,326 $795,000
Q3 2023 Nov 14, 2023	SELL	$16.46 - $19.99 $13,233 - $16,071	-804 Reduced 2.62%	29,918 $492,000
Q2 2023 Aug 14, 2023	SELL	$17.23 - $21.71 $89,837 - $113,195	-5,214 Reduced 14.51%	30,722 $614,000
Q1 2023 May 15, 2023	BUY	$18.08 - $24.55 $50,352 - $68,371	2,785 Added 8.4%	35,936 $679,000
Q4 2022 Feb 14, 2023	BUY	$20.4 - $24.73 $436,682 - $529,370	21,406 Added 182.26%	33,151 $751,000
Q3 2022 Nov 14, 2022	BUY	$22.29 - $35.04 $261,796 - $411,544	11,745 New	11,745 $310,000
Q3 2022 Nov 14, 2022	BUY	$22.29 - $35.04 $261,796 - $411,544	11,745 New	11,745 $310,000
Q2 2022 Aug 16, 2022	SELL	$19.35 - $35.04 $288,315 - $522,096	-14,900 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$24.62 - $34.31 $5,071 - $7,067	206 Added 1.4%	14,900 $495,000
Q4 2021 Feb 15, 2022	BUY	$30.19 - $40.28 $224,764 - $299,884	7,445 Added 102.7%	14,694 $480,000
Q3 2021 Nov 16, 2021	SELL	$29.09 - $45.68 $17,744 - $27,864	-610 Reduced 7.76%	7,249 $304,000
Q2 2021 Aug 16, 2021	SELL	$32.46 - $40.48 $150,744 - $187,989	-4,644 Reduced 37.14%	7,859 $306,000
Q1 2021 May 18, 2021	SELL	$33.61 - $49.95 $2.48 Million - $3.69 Million	-73,792 Reduced 85.51%	12,503 $426,000
Q4 2020 Feb 17, 2021	BUY	$26.52 - $49.35 $1.77 Million - $3.3 Million	66,816 Added 343.02%	86,295 $3.92 Million
Q3 2020 Nov 17, 2020	BUY	$27.01 - $40.26 $526,127 - $784,224	19,479 New	19,479 $536,000
Q4 2019 Feb 14, 2020	SELL	$34.54 - $44.87 $218,292 - $283,578	-6,320 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$31.84 - $50.88 $201,228 - $321,561	6,320 New	6,320 $225,000
Q4 2018 Feb 15, 2019	SELL	$39.11 - $75.15 $433,377 - $832,737	-11,081 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$65.0 - $82.15 $720,265 - $910,304	11,081 New	11,081 $837,000
Q4 2017 Feb 15, 2018	SELL	$26.0 - $34.6 $375,570 - $499,797	-14,445 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$18.0 - $32.95 $260,010 - $475,962	14,445	14,445 $476,000

Others Institutions Holding RGNX

# of Institutions

192

Shares Held

43.2M

Call Options Held

104K

Put Options Held

478K

View Full List

About REGENXBIO Inc.

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $327M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

More about RGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Regenxbio Inc. Transaction History